Brooklyn, NY, United States of America

Nam Fung Kar



 

Average Co-Inventor Count = 14.0

ph-index = 4

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovative Contributions of Nam Fung Kar

Introduction

Nam Fung Kar is a prominent inventor based in Brooklyn, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidiabetic compounds. With a total of 9 patents to his name, his work has the potential to impact the treatment of Type 2 diabetes and related conditions.

Latest Patents

Among his latest patents are novel antidiabetic tricyclic compounds. These compounds are characterized by their structural formula (I) and are recognized as agonists of the G-protein coupled receptor 40 (GPR40). They may be useful in the treatment, prevention, and suppression of diseases mediated by GPR40. Specifically, these compounds could aid in managing Type 2 diabetes mellitus and associated conditions such as obesity and lipid disorders, including mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.

Career Highlights

Nam Fung Kar is currently associated with Merck Sharp & Dohme Corporation, where he continues to innovate in the pharmaceutical sector. His work is instrumental in advancing treatments that address critical health issues.

Collaborations

He collaborates with notable colleagues, including Cheng Zhu and Lehua Chang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Nam Fung Kar's contributions to the field of pharmaceuticals, particularly in developing antidiabetic compounds, highlight his role as a significant inventor. His work not only advances scientific knowledge but also has the potential to improve the lives of many individuals affected by diabetes and related health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…